tuck, I'm not much of a source for deep understanding on this or anything. mz pointed out not long ago that shearwater offers a more complete service package with its peg-technology which may explain its success in recent 'wins'. It is discouraging, all the other pegggers, liposomers, sphere-aters, timerexers...but the point vlts makes is that, for protein therapeutics, polymasc has a successful track record of successful peg attachment without loss of effectiveness. Of course we will learn a lot more this year. Anyway, I sold my enzn (I originally bit on the sca technology, but it looks like its either not so popular or not being exploited) to get involved here.
To my knowledge, the peg-IP dispute is between branched/unbranched interferon peggers, not involving vlts...but I am now going to rush to edgar to make sure I didn't miss this in vlts's documents...I have sure thought all along that polymasc is quite owned and protected by vlts.
Wilder |
